Inovio Pharmaceuticals, Inc.
(NASDAQ : INO)

( )
INO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 3.41%494.361.0%$778.78m
DHRDanaher Corp. 2.22%242.560.7%$647.76m
MDTMedtronic Plc 1.57%125.850.6%$635.61m
ABTAbbott Laboratories 1.98%123.900.8%$617.22m
ALGNAlign Technology, Inc. 1.90%606.236.3%$364.21m
ISRGIntuitive Surgical, Inc. 2.40%804.722.3%$355.09m
NVCRNovoCure Ltd. 6.90%198.836.8%$305.81m
SYKStryker Corp. 1.85%256.961.3%$305.67m
BDXBecton, Dickinson & Co. 3.28%258.021.0%$297.83m
DXCMDexCom, Inc. 2.15%399.497.8%$278.71m
BSXBoston Scientific Corp. 2.98%40.851.0%$257.04m
IDXXIDEXX Laboratories, Inc. 2.78%528.463.7%$233.25m
BAXBaxter International, Inc. 1.36%85.791.8%$227.71m
EWEdwards Lifesciences Corp. 1.98%87.960.4%$222.64m
AAgilent Technologies, Inc. 0.95%133.221.6%$194.87m

Company Profile

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline include VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.